Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 69951 - 69975 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Silicon dioxide	Approved	CKM	1158	upregulated	Silicon Dioxide analog results in increased expression of CKM mRNA	19q13.32	A24194
Silicon dioxide	Approved	CKMT1A	548596	downregulated	Silicon Dioxide analog results in decreased expression of CKMT1A mRNA	15q15.3	A24195
Silicon dioxide	Approved	CKS2	1164	upregulated	Silicon Dioxide results in increased expression of CKS2 mRNA	9q22.2	A24196
Silicon dioxide	Approved	CLCA4	22802	downregulated	Silicon Dioxide results in decreased expression of CLCA4 mRNA	1p22.3	A24196
Silicon dioxide	Approved	CLCN7	1186	upregulated	Silicon Dioxide analog results in increased expression of CLCN7 mRNA	16p13.3	A24195
Silicon dioxide	Approved	CLDN1	9076	upregulated	Silicon Dioxide analog results in increased expression of CLDN1 mRNA	3q28	A24195
Silicon dioxide	Approved	CLDN1	9076	upregulated	Silicon Dioxide results in increased expression of CLDN1 mRNA	3q28	A24196
Silicon dioxide	Approved	CLDN12	9069	upregulated	Silicon Dioxide analog results in increased expression of CLDN12 mRNA	7q21.13	A24195
Silicon dioxide	Approved	CLDN14	23562	upregulated	Silicon Dioxide analog results in increased expression of CLDN14 mRNA	21q22.13	A24195
Silicon dioxide	Approved	CLDN4	1364	upregulated	Silicon Dioxide results in increased expression of CLDN4 mRNA	7q11.23	A24196
Silicon dioxide	Approved	CLDN5	7122	upregulated	Silicon Dioxide analog results in increased expression of CLDN5 mRNA	22q11.21	A24194
Silicon dioxide	Approved	CLDN7	1366	downregulated	Silicon Dioxide analog results in decreased expression of CLDN7 mRNA	17p13.1	A24195
Silicon dioxide	Approved	CLDN8	9073	downregulated	Silicon Dioxide results in decreased expression of CLDN8 mRNA	21q22.11	A24196
Silicon dioxide	Approved	CLDND2	125875	downregulated	Silicon Dioxide analog results in decreased expression of CLDND2 mRNA	19q13.41	A24195
Silicon dioxide	Approved	CLEC2D	29121	downregulated	Silicon Dioxide results in decreased expression of CLEC2D mRNA	12p13.31	A24196
Silicon dioxide	Approved	CLEC3B	7123	upregulated	Silicon Dioxide analog results in increased expression of CLEC3B mRNA	3p21.31	A24194
Silicon dioxide	Approved	CLEC4C	170482	upregulated	Silicon Dioxide analog results in increased expression of CLEC4C mRNA	12p13.31	A24195
Silicon dioxide	Approved	CLGN	1047	downregulated	Silicon Dioxide results in decreased expression of CLGN mRNA	4q31.1	A24196
Silicon dioxide	Approved	CLIC2	1193	upregulated	Silicon Dioxide results in increased expression of CLIC2 mRNA	Xq28	A24196
Silicon dioxide	Approved	CLIC3	9022	downregulated	Silicon Dioxide analog results in decreased expression of CLIC3 mRNA	9q34.3	A24194
Silicon dioxide	Approved	CLIC4	25932	upregulated	Silicon Dioxide analog results in increased expression of CLIC4 mRNA	1p36.11	A24195
Silicon dioxide	Approved	CLIP2	7461	downregulated	Silicon Dioxide analog results in decreased expression of CLIP2 mRNA	7q11.23	A24195
Silicon dioxide	Approved	CLIP2	7461	upregulated	Silicon Dioxide results in increased expression of CLIP2 mRNA	7q11.23	A24196
Silicon dioxide	Approved	CLK1	1195	upregulated	Silicon Dioxide analog results in increased expression of CLK1 mRNA	2q33.1	A24195
Silicon dioxide	Approved	CLK4	57396	upregulated	Silicon Dioxide results in increased expression of CLK4 mRNA	5q35.3	A24196

Displaying entries 69951 - 69975 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability